GH Axis Research
The growth hormone axis governs pituitary GH secretion and its downstream effector IGF-1. Key research compounds include CJC-1295 and Sermorelin — GHRH analogues that stimulate the anterior pituitary directly — and GHRP-6 and Ipamorelin, ghrelin-receptor agonists that trigger pulsatile GH release. IGF-1 LR3 is a recombinant, long-acting variant with a C-terminal extension studied for extended in vitro bioavailability, completing the GH axis research toolkit.

Ipamorelin
Mol. Wt.
711.85 g/mol
Purity
≥98%
CAS No.
170851-70-4

IGF-1 LR3
Mol. Wt.
9,117.57 g/mol
Purity
≥98%
CAS No.
946870-92-4

Sermorelin
Mol. Wt.
3,357.93 g/mol
Purity
≥98%
CAS No.
86168-78-7

GHRP-6
Mol. Wt.
873.01 g/mol
Purity
≥98%
CAS No.
87616-84-0

Tesamorelin
Mol. Wt.
5,135.9 g/mol
Purity
≥98%
CAS No.
218949-48-5

MGF (Mechano Growth Factor)
Mol. Wt.
2,867.16 g/mol
Purity
≥98%
CAS No.
162809-23-6

GHRP-2
Mol. Wt.
817.99 g/mol
Purity
≥98%
CAS No.
158861-67-7

CJC-1295 (No DAC)
Mol. Wt.
3,367.97 g/mol
Purity
≥98%
CAS No.
863288-34-0

CJC-1295 With DAC
Mol. Wt.
3,647.28 g/mol
Purity
≥98%
CAS No.
863288-34-0

IGF-1 DES
Mol. Wt.
~7,371 g/mol
Purity
≥98%
CAS No.
112603-35-7

Fragment 176-191
Mol. Wt.
1,815.12 g/mol
Purity
≥98%
CAS No.
66004-57-7

PEG-MGF
Mol. Wt.
~4,000–5,000 g/mol (variable PEG chain)
Purity
≥98%
CAS No.
N/A (PEGylated conjugate)

Hexarelin
Mol. Wt.
887.05 g/mol
Purity
≥98%
CAS No.
140703-51-1
